TICKERNOMICS Sign up
Last Update: 2023-12-23 06:03:53
FEMASYS INC ( FEMY ) https://www.femasys.com
0.89USD
Sector:
Healthcare
Industry:
Medical Instruments & Supplies
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
23.45%
-4.41%
FEMY
SPY
30.72%
FEMY
0.00%
SPY
112.82%
FEMY
0.00%
SPY
201.04%
FEMY
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
13.51
5.20
0.16
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-1.07
12.36
1.29
-83.84
0.00
-0.43
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-1670.18
64.73
-1094.80
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
3.86
-64.68
-66.93
0.00
Other Earnings and Cash Flow Stats:
FEMASYS INC ( FEMY ) Net Income TTM ($MM) is -12.65
FEMASYS INC ( FEMY ) Operating Income TTM ($MM) is -13.18
FEMASYS INC ( FEMY ) Owners' Earnings Annual ($MM) is 0.00
FEMASYS INC ( FEMY ) Current Price to Owners' Earnings ratio is 0.00
FEMASYS INC ( FEMY ) EBITDA TTM ($MM) is -11.99
FEMASYS INC ( FEMY ) EBITDA Margin is -1094.80%
Capital Allocation:
FEMASYS INC ( FEMY ) has paid 0.00 dividends per share and bought back -3.279537 million shares in the past 12 months
FEMASYS INC ( FEMY ) has reduced its debt by 1.201023 million USD in the last 12 months
Capital Structure:
FEMASYS INC ( FEMY ) Interest-bearing Debt ($MM) as of last quarter is 0
FEMASYS INC ( FEMY ) Annual Working Capital Investments ($MM) are -1
FEMASYS INC ( FEMY ) Book Value ($MM) as of last quarter is 10
FEMASYS INC ( FEMY ) Debt/Capital as of last quarter is 2%
Other Balance Sheet Stats:
FEMASYS INC ( FEMY ) has 8 million in cash on hand as of last quarter
FEMASYS INC ( FEMY ) has 2 million of liabilities due within 12 months, and long term debt 0 as of last quarter
FEMASYS INC ( FEMY ) has 15 common shares outstanding as of last quarter
FEMASYS INC ( FEMY ) has 0 million USD of preferred stock value
Academic Scores:
FEMASYS INC ( FEMY ) Altman Z-Score is -10.14 as of last quarter
FEMASYS INC ( FEMY ) Piotroski Score is 5.00 as of last quarter
Corporate Governance:
FEMASYS INC ( FEMY ) largest shareholder is Vanguard Group Inc owning 87623 shares at 0.08 ($MM) value
John Dyett(an insider) Bought 53500 shares of FEMASYS INC ( FEMY ) for the amount of $691755.00 on 2021-06-23
14.82% of FEMASYS INC ( FEMY ) is held by insiders, and 7.95% is held by institutions
FEMASYS INC ( FEMY ) went public on 2021-06-18
Other FEMASYS INC ( FEMY ) financial metrics:
FCF:-11.25
Unlevered Free Cash Flow:-10.37
EPS:-1.06
Operating Margin:-1670.18
Gross Profit Margin:64.73
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-153.09
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About FEMASYS INC ( FEMY ) :
Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.